Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature

Published:2010-03-08 Issue:6 Volume:101 Page:486-494
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Rebollo-Aguirre Ángel C.,Ramos-Font Carlos,Villegas Portero Román,Cook Gary J.R.,Llamas Elvira José Manuel,Romero Tabares Antonio

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.21525/fullpdf

Reference36 articles.

1. Epidemiology of lung cancer. ACCP evidence-based clinical practice guidelines (2nd edition);Alberg;Chest,2007

2. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition);Scott;Chest,2007

3. Treatment of non-small cell lung cancer-stage IIIA ACCP evidence-based clinical practice guidelines (2nd edition);Robinson;Chest,2007

4. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET;Hoekstra;J Nucl Med,2002

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer;Lung Cancer;2023-04

2. EBUS/EUS : quelle relation ? Pour quel résultat ?;Revue des Maladies Respiratoires Actualités;2017-09

3. Test–Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials;Journal of Nuclear Medicine;2017-05-04

4. Prognostic factors in non-small cell lung cancer patients who received neoadjuvant therapy and curative resection;Journal of Thoracic Disease;2016-07

5. Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer;European Journal of Cancer;2016-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3